Related Experiment Video
Updated: Nov 4, 2025

Improved Visualization and Quantitative Analysis of Drug Effects Using Micropatterned Cells
Published on: December 2, 2010
France's competitiveness in global pharmaceutical research: The situation is improving
Anne d'Andon1, Ariane Galaup2, Cecile Fabron1
1CEMKA, 43, boulevard Maréchal Joffre, 92340 Bourg-La-Reine, France.
France maintains its position in pharmaceutical clinical research, particularly in oncology and rare diseases. Despite challenges, areas of excellence and recent mobilization for COVID-19 research are key strengths for future growth.
Area of Science:
- Pharmaceutical research
- Clinical trials
- Drug development
Background:
- France's attractiveness in pharmaceutical clinical research is assessed biennially by the LEEM.
- The study measures global competitiveness for international clinical trials (CTs).
Purpose of the Study:
- To assess France's global competitiveness in international clinical trials.
- To identify strengths and areas of excellence in pharmaceutical research within France.
Main Methods:
- Descriptive and comparative analysis of data from ClinicalTrials.gov (2015-2019) and OSCAR (2018-2019).
- OSCAR database used to track administrative authorization and trial initiation processes in France.
Main Results:
- France was involved in 10.5% of global industrial CTs (2018-2019), ranking 4th in Europe.
- Oncology is an area of excellence, with France ranking 2nd in Europe for CTs in this area.
- Median time to first patient inclusion was 204 days, with slight reduction in initial authorization delays under new European regulation.
Conclusions:
- Areas of excellence like oncology and rare diseases, plus COVID-19 research, help France maintain pharmaceutical research.
- Strategic decisions are needed to further strengthen France's position in pharmaceutical research.
More Related Videos
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
08:43A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
Published on: March 10, 2017
Related Concept Videos
Drug Discovery: Overview
Drug Regulation
Drug Products: Biologics, Biosimilars and Interchangeables
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Preclinical Development: Overview
Drug Control Governance: Regulatory Bodies and Their Impact